Medical Letter on the CDC and FDA

Diabetes Type 2 Complications - Obesity and metabolic syndrome powerful predictors of diabetes type 2

Drug Resistance - CDC issues public reminder about proper antibiotic use

HIV/AIDS Prevention - One in five HIV-positive men knowingly put sexual partners at risk

Hepatitis C Virus - Testing for hepatitis C should be routine for persons at increased risk

Malaria - Travelers to Dominican Republic should take prophylaxis

AIDS/HIV Vaccines - New findings in the area of AIDS/HIV vaccines described

Adverse Drug Events - Consumer Group: Drug industry volunteer reporting plan falls short

Adverse Drug Events - U.S. FDA gives scientist permission to publish Vioxx safety data

Adverse Drug Reaction - Collaborative to study unanticipated serious adverse drug events using enTRUST

Air Pollution - Several hazardous air pollutants exceed cancer risk level in Portland

Anal Fissures - U.S. FDA issues not approvable letter for Cellegesic

Ankylosing Spondylitis - U.S. FDA approves REMICADE for patients with ankylosing spondylitis

Antimicrobials - Antimicrobial and antioxidant activities of medicinal plants reviewed

Argemone Oil - Argemone oil is genotoxic

Aspergillus - Intake of rice with Aspergillus and polybrominated diphenylethers studied

Atherosclerosis - Hepatic lipase can have a variable effect on atherosclerosis

Atrial Fibrillation - CE Mark clearance granted for the surgical ablation system

Bacteriology - Effect of oxalic acid on bacterial regrowth in drinking water studied

Bacteriology - Polychlorinated biphenyls degraded by newly isolated aerobic bacterium

Benzene - Xenobiotic metabolism and mechanism of benzene toxicity reviewed

Birth Defects - January 24-30, 2005 is Folic Acid Awareness Week

Bladder Cancer - No association between inorganic arsenic concentration and bladder cancer risk

Bovine Spongiform Encephalopathy - Canada, U.S. safeguards provide protection against BSE, USDA official says

Breast Cancer - New findings in breast cancer described

Breast Cancer - U.S. FDA clears use of automated scanning system for PathVysion DNA

Burkholderia - Patterns of genomic variation in Burkholderia species identified

Business Update - Generic pharmaceutical company announces filing of ANDA with U.S. FDA

Cadmium Exposure - Increased cadmium exposure may influence occurrence of disease

Cancer Survival - Reduced health care access and ability to pay decrease cancer survival

Cancer Therapy - Additional information provided to U.S. FTC for melanoma treatment

Cancer Therapy - Clolar wins FDA approval for common pediatric leukemia

Cancer Therapy - IND filed with U.S. FDA for AP5346

Candidemia - Antifungal medicine VFEND receives U.S. FDA approval for blood infection

Candidiasis - CaMIT1 inactivation reduces Candida albicans virulence

Cardiology - New findings in the area of cardiology described

Clinical Trials - Company provides update on cancer and HIV clinical-development programs

Clinical Trials - Results of autoimmune therapy in healthy volunteers study released

Cryptosporidium - Cyclospora oocysts are not ingested by the nematode Caenorhabditis elegans

Cystic Fibrosis - Biopharma company announces phase 1 study for PTC124

Depression - U.S. FDA grants ANDA for generic citalopram hydrobromide tablets for depression

Diabetes Therapy - Phloridzin improves hyperglycemia but not hepatic insulin resistance

Diagnostics - Company chosen to launch thyroid disease detection device

Diagnostics - Methods to analyze irradiated spicy vegetables described

Diagnostics - Microarray system cleared by U.S. FDA

Diagnostics - Neural networks used as statistical tools in epidemiological studies

Diagnostics - U.S. FDA clears standalone APTIMA test to detect chlamydia trachomatis

Diet & Nutritoin - Weight loss strategies work in people with prediabetes

Diphtheria - Proteins required for biosynthesis of diphthamide identified

Drug Development - FDA grants approval for Enjuvia for vasomotor symptoms

Drug Development - Genetically engineered animals in drug development reviewed

Drug Development - Investigational new drug application submitted for cancer candidate

Drug Development - Meeting with U.S. FDA completed for amoxicillin Pulsys phase III trial

Drug Development - NDA for Retaane submitted to U.S., European regulatory authorities

Drug Development - Pharmaceuticals company presents data on potency of antifungal, antibiotic drugs

Drug Resistance - ABC transporters have multiple functions in drug resistance

Emergency Contraception - Study: Readily available EC doesn't increase unprotected intercourse, STI risk

Emergency Contraception - U.S. ob/gyn group: Study findings put spotlight on controversial FDA OTC ruling

Environmental Health - Secondhand smoke linked to cognitive declines in children

Escherichia Coli - Ozone treatment alternative to pasteurization

Escherichia coli - High incidence of ESBLs among outpatient clinical E. coli isolates

Esophageal Variceal Bleeding - FDA issues approvable letter for Sanvar for esophageal variceal bleeding

Ethics - NIH whistleblower says government bungled AIDS study in Uganda

Finance - DNA-focused company announces third quarter 2004 financial results

Finance - Oncology-focused medical device company announces third quarter 2004 results

Food Contamination - F-specific coliphages detected by PCR in fresh market-ready produce